NIH $20 million transplant grant aims at better drugs, long-term organ tolerance Emory University News and Events Although belatacept avoids some of the toxicity of earlier transplant drugs, it is associated with higher rates of reversible acute rejection. And because it is a lifelong therapy, it still includes risks associated with a compromised immune system ... |
